Population Pharmacokinetics and Safety of Oral Tetra-Arsenic Tetra-Sulfide Formula in Pediatric Acute Promyelocytic Leukemia

BACKGROUND: An oral tetra-arsenic tetra-sulfide (AS(4)S(4)) formula has been recommended as an outpatient post-remission treatment for Chinese adults with acute promyelocytic leukemia (APL) but limited data are available for children. In this exploratory study, we aimed to evaluate the pharmacokinet...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Yang, Xin-Mei, Chen, Jing, Hu, Lei, Yang, Fan, Zhou, Yue, Zhao, Bei-Bei, Zhao, Wei, Zhu, Xiao-Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071704/
https://www.ncbi.nlm.nih.gov/pubmed/33911851
http://dx.doi.org/10.2147/DDDT.S305244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071704/
https://www.ncbi.nlm.nih.gov/pubmed/33911851
http://dx.doi.org/10.2147/DDDT.S305244

Ejemplares similares